Shares of IXICO plc (LON:IXI – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 8.12 ($0.11) and traded as low as GBX 8 ($0.10). IXICO shares last traded at GBX 8.63 ($0.11), with a volume of 520,125 shares traded.
IXICO Stock Performance
The stock has a market capitalization of £4.17 million, a price-to-earnings ratio of -215.63, a P/E/G ratio of -0.38 and a beta of 0.86. The company’s fifty day simple moving average is GBX 9.20 and its 200 day simple moving average is GBX 8.11. The company has a quick ratio of 4.90, a current ratio of 3.64 and a debt-to-equity ratio of 3.22.
Insider Activity at IXICO
In other news, insider Mark Warne bought 26,370 shares of the stock in a transaction dated Thursday, October 10th. The shares were bought at an average price of GBX 9 ($0.12) per share, for a total transaction of £2,373.30 ($3,089.43). 30.28% of the stock is owned by company insiders.
About IXICO
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
Featured Stories
- Five stocks we like better than IXICO
- Energy and Oil Stocks Explained
- California Resources Stock Could Be a Huge Long-Term Winner
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Comparing and Trading High PE Ratio Stocks
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.